4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-003030
Options or other derivatives
- Chief Medical Officer acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Litchev Boyan Vesselinov Chief Medical Officer | 2022-02-01 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
Loading xslF345X03/ownership.xml…